This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2005 Jun 24;308(5730):1858-60.

doi: 10.1126/science.308.5730.1858.

Pharmacogenomics. Going from genome to pill

Robert F Service

PMID: 15976283
DOI: 10.1126/science.308.5730.1858

Pharmacogenomics. Going from genome to pill

Robert F Service. Science. 2005.

. 2005 Jun 24;308(5730):1858-60.

doi: 10.1126/science.308.5730.1858.

Author

Robert F Service

PMID: 15976283
DOI: 10.1126/science.308.5730.1858

No abstract available

PubMed Disclaimer

Similar articles

With your genes? Take one of these, three times a day.
Abbott A. Abbott A. Nature. 2003 Oct 23;425(6960):760-2. doi: 10.1038/425760a. Nature. 2003. PMID: 14574377 No abstract available.
Pharmacogenomics: will the regulators approve?
Hodgson J, Marshall A. Hodgson J, et al. Nat Biotechnol. 1998 Mar;16(3):243-6. doi: 10.1038/nbt0398-243. Nat Biotechnol. 1998. PMID: 9528002 No abstract available.
Pharmacogenomics: an in-house advantage?
Borchardt PE. Borchardt PE. Drug Discov Today. 2006 Jan;11(1-2):1-3. doi: 10.1016/S1359-6446(05)03699-8. Drug Discov Today. 2006. PMID: 16478684 No abstract available.
Regulatory agency consideration of pharmacogenomics.
Pendergast MK. Pendergast MK. Exp Biol Med (Maywood). 2008 Dec;233(12):1498-503. doi: 10.3181/0806-S-207. Epub 2008 Oct 10. Exp Biol Med (Maywood). 2008. PMID: 18849547 Review.
[Pharmacogenomics: the quest for individualized therapy].
López-López M, Guerrero-Camacho JL, Familiar-López IM, Jung-Cook H, Corona-Vázquez T, Alonso-Vilatela ME. López-López M, et al. Rev Neurol. 2004 Dec 1-15;39(11):1063-71. Rev Neurol. 2004. PMID: 15597270 Review. Spanish.

See all similar articles

Cited by

Voriconazole therapeutic drug monitoring.
Smith J, Safdar N, Knasinski V, Simmons W, Bhavnani SM, Ambrose PG, Andes D. Smith J, et al. Antimicrob Agents Chemother. 2006 Apr;50(4):1570-2. doi: 10.1128/AAC.50.4.1570-1572.2006. Antimicrob Agents Chemother. 2006. PMID: 16569888 Free PMC article.
COVID19 Drug Repository: text-mining the literature in search of putative COVID19 therapeutics.
Tworowski D, Gorohovski A, Mukherjee S, Carmi G, Levy E, Detroja R, Mukherjee SB, Frenkel-Morgenstern M. Tworowski D, et al. Nucleic Acids Res. 2021 Jan 8;49(D1):D1113-D1121. doi: 10.1093/nar/gkaa969. Nucleic Acids Res. 2021. PMID: 33166390 Free PMC article.
Antifungal therapeutic drug monitoring: established and emerging indications.
Andes D, Pascual A, Marchetti O. Andes D, et al. Antimicrob Agents Chemother. 2009 Jan;53(1):24-34. doi: 10.1128/AAC.00705-08. Epub 2008 Oct 27. Antimicrob Agents Chemother. 2009. PMID: 18955533 Free PMC article. Review. No abstract available.
Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications.
Stockmann C, Constance JE, Roberts JK, Olson J, Doby EH, Ampofo K, Stiers J, Spigarelli MG, Sherwin CM. Stockmann C, et al. Clin Pharmacokinet. 2014 May;53(5):429-54. doi: 10.1007/s40262-014-0139-0. Clin Pharmacokinet. 2014. PMID: 24595533 Free PMC article. Review.
What is the role of therapeutic drug monitoring in antifungal therapy?
Smith JA. Smith JA. Curr Infect Dis Rep. 2009 Nov;11(6):439-46. doi: 10.1007/s11908-009-0064-9. Curr Infect Dis Rep. 2009. PMID: 19857383

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon